
No transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-12-24 | Gilbert Cisneros(D-CA31) | house | Sale | $1,001 - $15,000 |
| 2025-11-18 | Gilbert Cisneros(D-CA31) | house | Purchase | $1,001 - $15,000 |
| 2025-06-17 | Lisa McClain(R-MI09) | house | Purchase | $1,001 - $15,000 |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net sales | $7.10B+0.2% | $7.09B-4.0% | $7.39B+4.0% | $7.11B-3.2% | $7.34B |
| Cost of products sold | $3.89B-3.8% | $4.04B-9.7% | $4.48B-1.8% | $4.56B+10.1% | $4.14B |
| Gross profit | $3.21B+5.4% | $3.05B+4.8% | $2.91B+14.3% | $2.54B-20.4% | $3.20B |
| Selling and administrative expenses | $1.12B-3.7% | $1.17B-1.4% | $1.18B+24.0% | $954.0M-5.0% | $1.00B |
| Advertising costs | $770.0M-7.5% | $832.0M+13.4% | $734.0M+3.5% | $709.0M-10.3% | $790.0M |
| Research and development costs | $121.0M-4.0% | $126.0M-8.7% | $138.0M+4.5% | $132.0M-11.4% | $149.0M |
| Loss on divestiture | $118.0M-50.8% | $240.0M | $0 | $0 | — |
| Pension settlement charge | $0-100.0% | $171.0M | $0 | $0 | — |
| Goodwill, trademark and other asset impairments | $0 | $0-100.0% | $445.0M | $0-100.0% | $329.0M |
| Interest expense | $88.0M-2.2% | $90.0M+0.0% | $90.0M-15.1% | $106.0M+7.1% | $99.0M |
| Other (income) expense, net | -$86.0M-458.3% | $24.0M-70.0% | $80.0M+116.2% | $37.0M+151.4% | -$72.0M |
| Earnings before income taxes | $1.08B+170.9% | $398.0M+67.2% | $238.0M | — | — |
| Income taxes | $254.0M+139.6% | $106.0M+37.7% | $77.0M-43.4% | $136.0M-24.9% | $181.0M |
| Net earnings | $824.0M+182.2% | $292.0M+81.4% | $161.0M-65.8% | $471.0M-34.5% | $719.0M |
| Less: Net earnings attributable to noncontrolling interests | $14.0M+16.7% | $12.0M+0.0% | $12.0M+33.3% | $9.0M+0.0% | $9.0M |
| Net earnings attributable to Clorox | $810.0M+189.3% | $280.0M+87.9% | $149.0M-67.7% | $462.0M-34.9% | $710.0M |
| Basic net earnings per share (in dollars per share) | $6.6M+190.3% | $2.3M+86.8% | $1.2M-67.7% | $3.8M-33.7% | $5.7M |
| Diluted net earnings per share (in dollars per share) | $6.5M+189.8% | $2.3M+87.5% | $1.2M-67.8% | $3.7M-33.2% | $5.6M |
| Basic (in shares) | $123.53B-0.5% | $124.17B+0.5% | $123.59B+0.4% | $123.11B-2.0% | $125.57B |
| Diluted (in shares) | $124.29B-0.4% | $124.80B+0.5% | $124.18B+0.2% | $123.91B-2.7% | $127.30B |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Why Clorox (CLX) Shares Are Getting Obliterated Today
Earnings scoreboard: 11 of 12 consumer staple names beat earnings estimates this week
3 Profitable Stocks That Concern Us
Why Clorox (CLX) Is Down 11.7% After Cutting 2026 Outlook Amid GOJO Dilution And Inflation